Frontiers in Pharmacology | Pharmacogenetics and Pharmacogenomics

Original Research

Published on 14 Aug 2023

Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States

in Pharmacogenetics and Pharmacogenomics

Lauren K. Lemke
Benish Alam
Roy Williams
Petr Starostik
Larisa H. Cavallari
Emily J. Cicali
Kristin Wiisanen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1179364

6,186 views
16 citations

Brief Research Report

Published on 11 Aug 2023

Pharmacogenomic implications of the differential distribution of CYP2C9 metabolic phenotypes among Latin American populations

in Pharmacogenetics and Pharmacogenomics

Guilherme Suarez-Kurtz

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1246765

1,684 views

Case Report

Published on 10 Aug 2023

Deletion of the CYP2D6 gene as a likely explanation for the serious side effects of the antipsychotic drug pimozide: a case report

in Pharmacogenetics and Pharmacogenomics

Fernando Facal
Begoña Portela
Almudena Gil-Rodríguez
Francisco Barros
Olalla Maroñas
Angel Carracedo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1237446

3,492 views
6 citations

Editorial

Published on 08 Aug 2023

Editorial: Editor’s feature: negative findings in pharmacogenetics and pharmacogenomics

in Pharmacogenetics and Pharmacogenomics

José A. G. Agúndez
Pedro Ayuso
Luis A. Quiñones
Elena García-Martín

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1267344

1,434 views
2 citations

Original Research

Published on 08 Aug 2023

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma

in Pharmacogenetics and Pharmacogenomics

Binliang Gan
Youwu He
Yonggang Ma
Linfeng Mao
Chuanjie Liao
Ganlu Deng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1167418

3,332 views
3 citations

Original Research

Published on 04 Aug 2023

SNPs in cytochrome P450 genes decide on the fate of individuals with genetic predisposition to Parkinson’s disease

in Pharmacogenetics and Pharmacogenomics

Polina Petkova-Kirova
Stephan Baas
Gudrun Wagenpfeil
Philip Hartz
Marcus Michael Unger
Rita Bernhardt

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1244516

3,477 views
4 citations

Original Research

Published on 27 Jul 2023

A frequent CYP2D6 variant promotes skipping of exon 3 and reduces CYP2D6 protein expression in human liver samples

in Pharmacogenetics and Pharmacogenomics

Joseph M. Collins
Hannah Lester
Samia Shabnaz
Danxin Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1186540

2,630 views
4 citations

Systematic Review

Published on 26 Jul 2023

Effects of CYP3A4*22 polymorphism on trough concentration of tacrolimus in kidney transplantation: a systematic review and meta-analysis

in Pharmacogenetics and Pharmacogenomics

Jung Sun Kim
Sunyoung Shim
Jeong Yee
Kyung Hee Choi
Hye Sun Gwak

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1201083

3,926 views
2 citations

Original Research

Published on 13 Jul 2023

The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam

in Pharmacogenetics and Pharmacogenomics

Ai-Hoc Nguyen
Chonlaphat Sukasem
Quy Ngoc Nguyen
Hong Tham Pham

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1217516

3,088 views
3 citations

Case Report

Published on 11 Jul 2023

Case report: metoclopramide induced acute dystonic reaction in adolescent CYP2D6 poor metabolizers

in Pharmacogenetics and Pharmacogenomics

Franz-Martin Fink
Marta Bognar
Petra Hengl
Markus Paulmichl
Charity Nofziger

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1201566

4,702 views
4 citations

Original Research

Published on 04 Jul 2023

CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study

in Pharmacogenetics and Pharmacogenomics

Laurence McEvoy
Joanne Cliff
Daniel F Carr
Andrea Jorgensen
Rosemary Lord
Munir Pirmohamed

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1178421

3,827 views
2 citations

Original Research

Published on 27 Jun 2023

Role of endogenous and exogenous antioxidants in risk of six cancers: evidence from the Mendelian randomization study

in Pharmacogenetics and Pharmacogenomics

Jiahao Zhu
Jie Lian
Xin Wang
Ren Wang
Xiangyi Pang
Benjie Xu
Xing Wang
Chenyang Li
Shengjun Ji
Haibo Lu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1185850

7,853 views
5 citations

Original Research

Published on 22 Jun 2023

Association between genetic polymorphism, severity, and treatment response among COVID-19 infected Egyptian patients

in Pharmacogenetics and Pharmacogenomics

Abdelrahman Alaa
Neven Sarhan
Mohamed Gamal Lotfy El-Ansary
Naglaa Samir Bazan
Khaled Farouk
Raed Shahat Ismail
Mona Farag Schalaan
Adel R. A. Abd-Allah

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1209286

3,187 views
6 citations

Brief Research Report

Published on 22 Jun 2023

Characterization of complex structural variation in the CYP2D6-CYP2D7-CYP2D8 gene loci using single-molecule long-read sequencing

in Pharmacogenetics and Pharmacogenomics

Amy J. Turner
Ashley D. Derezinski
Andrea Gaedigk
Mark E. Berres
David B. Gregornik
Keith Brown
Ulrich Broeckel
Gunter Scharer

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1195778

5,872 views
14 citations

Original Research

Published on 16 Jun 2023

Mendelian randomization analysis identified tumor necrosis factor as being associated with severe COVID-19

in Pharmacogenetics and Pharmacogenomics

Hongfei Song
Na Lei
Ling Zeng
Xiuyan Li
Cen Jiang
Quansheng Feng
Yue Su
Jibin Liu
Jie Mu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1171404

3,494 views
6 citations

Editorial

Published on 13 Jun 2023

Editorial: The utilization of bench-to-bedside approaches in pharmacogenomics

in Pharmacogenetics and Pharmacogenomics

Eric Rytkin
Kseniia Kriukova
Natalia Denisenko
Dmitriy Ivashchenko
Michael Zastrozhin
Karin Mirzaev
Dmitry Sychev

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1234219

1,469 views